Breaking News Instant updates and real-time market news.

RAND

Rand Capital

$2.95

(0.00%)

08:36
04/22/19
04/22
08:36
04/22/19
08:36

User-Friendly urges Rand stockholders to vote against East transaction

User-Friendly Phone Book announced that it has sent a letter to the stockholders of Rand notifying them that User-Friendly plans on filing with the Securities and Exchange Commission, and delivering to stockholders, its own proxy materials, which will detail User-Friendly's reasons for voting against all of the proposals to be voted upon at the special meeting of stockholders of Rand, scheduled for May 16, 2019. The letter read, in part, "I am Bruce Howard, CrEO of User-Friendly Phone Book, the largest individual stockholder of Rand Capital Corporation. User-Friendly is very concerned that Rand's proposed transaction with East Asset Management is not in the best interests of the company or its stockholders. We plan on filing a proxy statement with the Securities and Exchange Commission and will soon provide you with information regarding why User-Friendly believes that the terms of the proposed transaction with East are inadequate and not in the best interests of the company or its stockholders. User-Friendly urges you to refrain from voting until you have had an opportunity to review our proxy materials and to understand better our objections to the proposed transaction with East. You deserve the opportunity to review the information regarding why we believe the terms of the proposed transaction are inadequate and to decide for yourself what best serves your interests. Under the Stock Purchase Agreement with East, Rand has agreed to sell control of the company for $3.00 per share, or aggregate consideration of $25M n in a mix of cash and private investments. For the reasons that will be explained in detail in our proxy materials to be delivered to you shortly, we intend to vote AGAINST the proposed transaction. By now you have likely received the proxy materials and a proxy card from Rand for the Special Meeting scheduled to be held on May 16, 2019. The Rand proxy statement, among other things, is asking you to approve the proposed transaction with East. Please do NOT respond to any solicitation made by Rand's management and do NOT return a proxy card voting for the proposed transaction with East. You will soon be receiving our proxy statement and our WHITE proxy card urging you to vote AGAINST the proposed transaction with East by voting AGAINST each proposal to be voted upon at the Special Meeting. Our interests are aligned with yours-to maximize the value of our investment in Rand. "

  • 02

    May

  • 16

    May

TODAY'S FREE FLY STORIES

AXTA

Axalta Coating

$25.82

0.03 (0.12%)

07:10
06/19/19
06/19
07:10
06/19/19
07:10
Hot Stocks
Axalta Coating up 14% after announcing review of strategic alternatives »

In pre-market trading,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$276.80

1.21 (0.44%)

07:10
06/19/19
06/19
07:10
06/19/19
07:10
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:10
06/19/19
06/19
07:10
06/19/19
07:10
General news
FX Update: The dollar has seen moderate softness »

FX Update: The dollar has…

NBRV

Nabriva Therapeutics

$2.11

0.045 (2.18%)

07:09
06/19/19
06/19
07:09
06/19/19
07:09
Hot Stocks
Nabriva Therapeutics submits Type A Meeting Request to FDA for CONTEPO »

Nabriva Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Aug

ADBE

Adobe

$276.80

1.21 (0.44%)

07:09
06/19/19
06/19
07:09
06/19/19
07:09
Upgrade
Adobe rating change  »

Adobe upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRNE

Sorrento Therapeutics

$3.69

0.06 (1.65%)

07:08
06/19/19
06/19
07:08
06/19/19
07:08
Hot Stocks
Sorrento Therapeutics CEO to provide updates on CD38 immunotherapies »

Sorrento Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTEC

Intec Pharma

$4.78

-0.02 (-0.42%)

07:07
06/19/19
06/19
07:07
06/19/19
07:07
Hot Stocks
Intec Pharma's Accordion Pill meets primary endpoint in PK study »

Intec Pharma announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMPH

KemPharm

$1.82

0.13 (7.69%)

07:07
06/19/19
06/19
07:07
06/19/19
07:07
Initiation
KemPharm initiated  »

KemPharm initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MCRB

Seres Therapeutics

$2.61

0.16 (6.53%)

07:06
06/19/19
06/19
07:06
06/19/19
07:06
Hot Stocks
Seres Therapeutics provides statement regarding FDA safety alert for FMT use »

Seres Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$276.80

1.21 (0.44%)

07:06
06/19/19
06/19
07:06
06/19/19
07:06
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUB

Cubic

$60.46

1.205 (2.03%)

07:04
06/19/19
06/19
07:04
06/19/19
07:04
Hot Stocks
Cubic announces sale of commercial properties in San Diego, Orlando for $46M »

Cubic announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SYX

Systemax

$20.56

0.16 (0.78%)

07:03
06/19/19
06/19
07:03
06/19/19
07:03
Conference/Events
Systemax management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 25

    Sep

PLXP

PLx Pharma

$4.93

-0.07 (-1.40%)

07:03
06/19/19
06/19
07:03
06/19/19
07:03
Hot Stocks
PLx Pharma says 'on track' to file VAZALORE submission by year-end »

PLx Pharma announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDB

MongoDB

07:03
06/19/19
06/19
07:03
06/19/19
07:03
Recommendations
MongoDB analyst commentary  »

MongoDB price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

SMLP

Summit Midstream

$6.90

0.13 (1.92%)

07:03
06/19/19
06/19
07:03
06/19/19
07:03
Downgrade
Summit Midstream rating change  »

Summit Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PT

Pintec Technology

$4.38

-0.04 (-0.90%)

07:02
06/19/19
06/19
07:02
06/19/19
07:02
Hot Stocks
Pintec Technology expands partnership with 1an.com »

Pintec Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

07:02
06/19/19
06/19
07:02
06/19/19
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 6/14 MBA Mortgage…

CTLT

Catalent

$50.48

-0.1 (-0.20%)

, BMY

Bristol-Myers

$47.79

-0.42 (-0.87%)

07:02
06/19/19
06/19
07:02
06/19/19
07:02
Hot Stocks
Catalent tu purchase Bristol-Myers' manufacturing facility in Italy »

Catalent (CTLT) has…

CTLT

Catalent

$50.48

-0.1 (-0.20%)

BMY

Bristol-Myers

$47.79

-0.42 (-0.87%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

  • 16

    Sep

AXTA

Axalta Coating

$25.82

0.03 (0.12%)

07:02
06/19/19
06/19
07:02
06/19/19
07:02
Hot Stocks
Axalta Coating initiates review of strategic alternatives »

Axalta Coating announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RM

Regional Management

$25.55

0.01 (0.04%)

07:01
06/19/19
06/19
07:01
06/19/19
07:01
Conference/Events
Regional Management management to meet with JMP Securities »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 13

    Nov

ADBE

Adobe

$276.80

1.21 (0.44%)

06:58
06/19/19
06/19
06:58
06/19/19
06:58
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NKE

Nike

$84.30

2.21 (2.69%)

06:58
06/19/19
06/19
06:58
06/19/19
06:58
Recommendations
Nike analyst commentary  »

Nike survey shows weaker…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

ADBE

Adobe

$276.80

1.21 (0.44%)

06:57
06/19/19
06/19
06:57
06/19/19
06:57
Recommendations
Adobe analyst commentary  »

Adobe growth to slow over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BA

Boeing

$374.21

19.31 (5.44%)

06:56
06/19/19
06/19
06:56
06/19/19
06:56
Hot Stocks
Qatar Airways to purchase five additional Boeing 777 Freighters for $1.8B »

Qatar Airways announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jul

GE

General Electric

$10.42

0.38 (3.78%)

06:54
06/19/19
06/19
06:54
06/19/19
06:54
Recommendations
General Electric analyst commentary  »

General Electric…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.